Consideration of the relationship between COVID-19 severe respiratory failure and pancreatic injury

Consideration of the relationship between COVID-19 severe respiratory failure and pancreatic injury - Pancreatic injury in patients with COVID-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045201

Enrollment

300

Registered

2021-08-20

Start date

2020-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19 patients with severe respiratory failure admitted to the ICU between March 1, 2020 and December 31, 2025.

Exclusion criteria

Exclusion criteria: Patients who are judged as inappropriate subjects by the researcher, etc., or subjects who voluntarily request exclusion.

Design outcomes

Primary

Measure	Time frame
Changes in blood amylase, pancreatic amylase, and lipase due to body position and administered drugs, and associated diagnostic imaging	—

Countries

Japan

Contacts

Public ContactSatoshi Komatsu

Fujita Health University School of Medicine Department of Anesthesiology and Critical Care Medicine

mind_koma@yahoo.co.jp0562-93-2270

Outcome results